Gilead Sciences Overview
Gilead Sciences Target Price
Analysts' 12-month price predictions for GILD.
Get informed when a big investor buys or sells
+ FollowShare Price
$128.99
Average Target Price
$164.10
27.2% upside
27.2% upside20 analysts in the last 4 months
High: $180 | Low: $145
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-20 | Maxim GroupMichael Okunewitch | $165 | 27.9% upside |  |
| 2026-05-10 | Morgan Stanley | $168 | 30.2% upside | |
| 2026-05-08 | Truist Financial | $157 | 21.7% upside | |
| 2026-04-10 | Morgan Stanley | $175 | 35.7% upside | |
| 2026-04-08 | Truist FinancialGregory Renza | $155 | 20.2% upside | |
| 2026-03-10 | JefferiesAkash Tewari | $180 | 39.5% upside | |
| 2026-02-19 | Barclays | $155 | 20.2% upside | |
| 2026-02-19 | Mizuho Securities | $170 | 31.8% upside | |
| 2026-02-18 | UBS | $175 | 35.7% upside | |
| 2026-02-11 | ScotiabankLouise Chen | $177 | 37.2% upside | |
| 2026-02-11 | BernsteinCourtney Breen | $160 | 24% upside | |
| 2026-02-11 | Morgan Stanley | $171 | 32.6% upside | |
| 2026-02-11 | Truist Financial | $162 | 25.6% upside | |
| 2026-02-11 | Truist Financial | $152 | 17.8% upside | |
| 2026-02-11 | Oppenheimer | $165 | 27.9% upside | |
| 2026-02-11 | Cantor Fitzgerald | $155 | 20.2% upside | |
| 2026-02-11 | NeedhamJoseph Stringer | $170 | 31.8% upside | |
| 2026-02-11 | Robert W. Baird | $145 | 12.4% upside | |
| 2026-02-11 | BMO CapitalEvan Seigerman | $160 | 24% upside | |
| 2026-02-11 | Wells FargoMohit Bansal | $165 | 27.9% upside | |
| 2026-01-27 | Truist Financial | $145 | 12.4% upside | |
| 2026-01-26 | BMO CapitalEvan David Seigerman | $150 | 16.3% upside | |
| 2026-01-26 | UBS | $155 | 20.2% upside | |
| 2026-01-13 | Morgan Stanley | $150 | 16.3% upside | |
| 2026-01-07 | UBSMichael Yee | $145 | 12.4% upside | |
| 2025-12-29 | BernsteinCourtney Breen | $135 | 4.7% upside | |
| 2025-12-15 | Wolfe ResearchAlexandria Hammond | $150 | 16.3% upside | |
| 2025-12-12 | Morgan Stanley | $151 | 17.1% upside | |
| 2025-12-10 | HSBC | $133 | 3.1% upside | |
| 2025-11-25 | BMO CapitalEvan David Seigerman | $135 | 4.7% upside | |
| 2025-11-24 | Truist FinancialGregory Renza | $140 | 8.5% upside | |
| 2025-11-20 | Mizuho Securities | $140 | 8.5% upside | |
| 2025-10-31 | Morgan StanleyTerence Flynn | $147 | 14% upside | |
| 2025-10-31 | RBC Capital | $105 |  18.6% downside | |
| 2025-10-31 | Wells Fargo | $145 | 12.4% upside | |
| 2025-10-09 | Cantor FitzgeraldCarter Gould | $135 | 4.7% upside | |
| 2025-10-06 | Wells Fargo | $140 | 8.5% upside | |
| 2025-08-11 | Deutsche BankJames Shin | $135 | 4.7% upside | |
| 2025-08-08 | Robert W. BairdBrian Skorney | $108 | 16.3% downside | |
| 2025-08-08 | Morgan StanleyTerence Flynn | $143 | 10.9% upside | |
| 2025-07-14 | Leerink PartnersDavid Risinger | $114 | 11.6% downside | |
| 2025-06-18 | Morgan StanleyTerence Flynn | $135 | 4.7% upside | |
| 2025-04-22 | Cantor FitzgeraldCarter Gould | $125 | 3.1% downside | |
| 2025-03-11 | Morgan StanleyTerence Flynn | $130 | 0.8% upside | |
| 2025-03-05 | Johnson Rice | $126 | 2.3% downside | |
| 2025-03-04 | Oppenheimer | $132 | 2.3% upside | |
| 2025-01-07 | RBC CapitalBrian Abrahams | $83 | 35.7% downside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $105 | 18.6% downside | |
| 2024-10-21 | BMO CapitalEvan David Seigerman | $94 | 27.1% downside | |
| 2024-10-21 | Leerink PartnersAndrew Berens | $96 | 25.6% downside | |